Current Studies

HPV Protocols Protocol Title
AMC-045 Phase II Trial Of Combined Modality Therapy Plus Cetuximab in HIV-Associated Anal Carcinoma
AMC-054 (India) A Single-Arm, Open-Label Pilot Study of the Safety and Immunogenicity of the Merck Quadrivalent Human Papillomavirus Vaccine among HIV-Positive Women in India
AMC-058 A Companion Protocol To Evaluate Anogenital Human Papillomavirus (HPV) Infection And Anogenital Squamous Intraepithelial Lesions (ASIL) In Patients Participating In AMC Clinical Trials
AMC-060 (India) HPV Infection in Indian HIV-Seropositive Men who have Sex with Men (MSM)
KS Protocols Protocol Title
AMC-050 (Brazil) Pilot Study of Liposomal Daunorubicin Citrate in Patients With HIV-Related Kaposi's Sarcoma
AMC-059Phase I/II Trial of Anti-VEGF Small Molecule PTC299 in Patients With HIV-Related Kaposi's Sarcoma
Lymphoma Protocols Protocol Title
AMC-048 Prospective Phase II Study Of A High Dose, Short Course Regimen (R-CODOX-M/IVAC) Including CNS Penetration And Intensive IT Prophylaxis In HIV-Associated Burkitt’s And Burkitt’s-Like Lymphoma
AMC-053 Safety and Efficacy Pilot Trial of the Anti-Viral and Anti-Tumor Activity of Velcade Combined with (R)ICE in Subjects with EBV and/or HHV-8 positive Relapsed/Refractory AIDS-Associated Non-Hodgkin’s Lymphoma
NADC Protocols Protocol Title
AMC-061 A Phase I/Pharmacokinetic Study of Sunitinib in Patients with Cancer who also have HIV and are on HAART Therapy
Lab Protocols Protocol Title
AMC-064 Evaluation of Clonal Ig DNA in Plasma from Patients with Aggressive B-cell Lymphomas